xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subjectArtikkelit"HYPERTROPHY"

Characteristics of 9194 patients with left ventricular hypertrophy. The LIFE Study

Dahlöf B; Devereux RB; Julius S; Kjeldsen SE; Beevers G; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; LIFE Study Group; Tuomilehto J; Sarti C
Hypertension (1998)

Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later

Sundström J; Lind L; Vessby B; Andrén B; Aro A; Lithell HO
Circulation (2001)

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The Losartan Intervention For Endpoints (LIFE). Reduction in Hypertension Study

Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B; LIFE Study Group; Sarti C; Tuomilehto J
Hypertension (2000)

Effects of Losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A Losarthan Intervention For Endpoint Reduction (LIFE) Substudy

Kjeldsen SE; Dahlöf B; Devereux RB; Julius S; Aurup P; Edelman J; Beevers G; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H; for the LIFE Study Group; Sarti C; Tuomilehto J; Ylihärsilä H
JAMA (2003)

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE Study

Wachtell K; Bella JN; Liebson PR; Gerdts E; Dahlöf B; Aalto T; Roman MJ; Papademetriou V; Ibsen H; Rokkedal J; Devereux RB; Sarti C; Tuomilehto J
Hypertension (2000)

Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe

Bots ML; Nikitin Y; Salonen JT; Elwood PC; Malyutina S; Freire de Concalves A; Sivenius J; Di Carlo A; Lagiou P; Tuomilehto J; Koudstaal PJ; Grobbee DE
J EPIDEMIOL COMMUNITY HEALTH : Suppl 1 (2002)

Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial

Van Hoof R; EWPHE Group; Tuomilehto J; Puska P
Am J Med : 3A (1991)

Artikkelit - Selaus asiasanan mukaan "HYPERTROPHY"

Characteristics of 9194 patients with left ventricular hypertrophy. The LIFE Study ﻿

Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later ﻿

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The Losartan Intervention For Endpoints (LIFE). Reduction in Hypertension Study ﻿

Effects of Losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A Losarthan Intervention For Endpoint Reduction (LIFE) Substudy ﻿

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population. The LIFE Study ﻿

Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe ﻿

Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial ﻿